SCHEMBL1509041

SCHEMBL1509041

CCCCCCCCC1(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
THRB P10828 1/20 0.51
HTT P42858 1/20 0.51
MAPT P10636 1/20 0.51
TSHR P16473 3/20 0.43
LMNA P02545 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPK1 P28482 2/20 0.38
USP2 O75604 1/20 0.38
CYP3A4 P08684 1/20 0.38
CASP1 P29466 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLCO1B3 Q9NPD5 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
EPHX2 P34913 1/20 0.32
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416283 1.00 MEN1 (0.51) MEN1KMT2ATHRBHTTMAPT
SCHEMBL5667974 0.91 MEN1 (0.40) MEN1KMT2ATHRBHTTMAPT
SCHEMBL7118184 0.91 MEN1 (0.40) MEN1KMT2ATHRBHTTMAPT
SCHEMBL27983412 0.84 TSHR (0.38) MEN1KMT2ATHRBHTTMAPT
SCHEMBL31695356 0.79 TSHR (0.39) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL5667972 0.77 LMNA (0.38) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL7118182 0.77 LMNA (0.38) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL1509039 0.76 LMNA (0.37) MEN1KMT2ATHRBHTTMAPT
Ethylene Glycol SCHEMBL8416280 0.76 LMNA (0.37) MEN1KMT2ATHRBHTTMAPT
SCHEMBL8324723 0.75 MEN1 (0.42) MEN1KMT2ATHRBHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5357636-A Flexible protective medical gloves and methods for their use DRESDNER JR KARL P (US) 1994-10-25 US claimed
US-5335373-A Protective medical gloves and methods for their use DRESDNER JR KARL P (US) 1994-08-09 US claimed
US-8003076-B2 Methods for conducting metabolic analyses TARGET DISCOVERY, INC. (US) 2011-08-23 US disclosed
EP-1084396-B9 ELECTROPHORESIS APPARATUS AND METHOD UNIV TEXAS (US) 2011-07-13 EP disclosed
EP-2293056-A2 A method for analysing a metabolic pathway Target Discovery, Inc. (US) 2011-03-09 EP disclosed
EP-1084396-B1 ELECTROPHORESIS APPARATUS AND METHOD UNIV TEXAS (US) 2011-03-02 EP disclosed
US-20090010915-A1 Methods for Conducting Metabolic Analyses TARGET DISCOVERY, INC. (US) 2009-01-08 US disclosed
US-7435406-B2 Methods for conducting metabolic analyses TARGET DISCOVERY, INC. (US) 2008-10-14 US disclosed
EP-1194768-A4 POLYPEPTIDE FINGERPRINTING METHODS, METABOLIC PROFILING, AND BIOINFORMATICS DATABASE TARGET DISCOVERY INC (US) 2008-03-26 EP disclosed
US-20080020376-A1 Enriched Cdna Expression Libraries and Methods of Making and Using Same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-01-24 US disclosed
US-7211376-B2 Polypeptide fingerprinting methods TARGET DISCOVERY, INC. (US) 2007-05-01 US disclosed
WO-2002014851-A2 ELECTROPHORESIS APPARATUS AND METHOD LYNX THERAPEUTICS, INC. (US) 2002-02-21 WO disclosed
US-6214191-B1 SEPARATION COMPONENTS WITHIN A SAMPLE LYNX THERAPEUTICS, INC. 2001-04-10 US disclosed
WO-2000063683-A1 POLYPEPTIDE FINGERPRINTING METHODS, METABOLIC PROFILING, AND BIOINFORMATICS DATABASE TARGET DISCOVERY, INC. (US) 2000-10-26 WO disclosed
US-6013165-A APPARATUS, SYSTEM, AND METHOD FOR TWO DIMENSIONAL ELECTROPHORESIS OF ANALYTES OF INTEREST, PARTICULARLY POLYPEPTIDES LYNX THERAPEUTICS, INC. (US) 2000-01-11 US disclosed
EP-0738391-A1 RADIAL FLOW ASSAY INTRACEL CORPORATION (US) 1996-10-23 EP disclosed
US-5547833-A Radial flow assay, delivering member, test kit, and methods INTRACEL CORPORATION (US) 1996-08-20 US disclosed
WO-1995018970-A1 RADIAL FLOW ASSAY INTRACEL CORPORATION (US) 1995-07-13 WO disclosed
US-5357636-A Flexible protective medical gloves and methods for their use DRESDNER JR KARL P (US) 1994-10-25 US disclosed
US-5335373-A Protective medical gloves and methods for their use DRESDNER JR KARL P (US) 1994-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090010915-A1 Methods for Conducting Metabolic Analyses PC, FAH, CYP27A1 MEN1 866/4885KMT2A 3864/4885THRB 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.